VivoSeq
Other

Cheilitis

7

Pipeline Programs↗

0

Active Trials↗

3

Companies Involved↗

Cheilitis is an early-stage landscape with 7 programs across 3 companies. The most active players are Bayer, Graceway Pharmaceuticals, LLC, LEO Pharma. 2 therapies are approved.

Intelligence

Pipeline Metrics

Competitive Density

31/100

Pipeline Velocity

0/100

Mech. Concentration

100/100

Completion Rate

50/100

Attrition Rate

43/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Bayer logo

Bayer

1 program

Phase 1G

Graceway Pharmaceuticals, LLC

1 program

Phase 1LEO Pharma logo

LEO Pharma

1 program

Phase 2

Pipeline

Programs by Phase

Analysis

Trial Status

7

clinical trials

Completed3 · 43%
Withdrawn2 · 29%
Unknown status1 · 14%
Terminated1 · 14%

Clinical Trials

Trial Activity

7 trials

Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis
Completed·—·Phase 4·NCT02409732·24 enrolled
Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy
Completed·NNorwegian University of Science and Technology·Phase 4·NCT00849992·53 enrolled
Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis
Completed·—·Phase 1·NCT02198469·33 enrolled
Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis
Terminated·HHospital de Clinicas de Porto Alegre·Phase 1·NCT04219358·49 enrolled
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis
Withdrawn·NNova Scotia Health Authority·Phase 4·NCT04744103
Evaluation of Ingenol Mebutate for Actinic Cheilitis Treatment
Withdrawn·IInstituto Nacional de Cancer, Brazil·Phase 1/2·NCT03452566
Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial
Unknown status·IInstituto Nacional de Cancer, Brazil·Phase 2·NCT03990636·40 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)